's Avatar

@mghsteelelabs.bsky.social

11 Followers  |  9 Following  |  10 Posts  |  Joined: 19.05.2025  |  1.6791

Latest posts by mghsteelelabs.bsky.social on Bluesky

@mit.edu @harvard.edu

07.01.2026 17:37 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Preview
Nutrient requirements of organ-specific metastasis in breast cancer Nature - How the complex interplay between multiple nutrients within the microenvironment dictates potential sites of metastatic cancer growth is explored.

Publication Alert @natureportfolio.nature.com 🚨 - Organ-specific breast cancer metastasis reflects complex nutrient–tumor interactions, not single metabolites. Purine synthesis is a conserved vulnerability. rdcu.be/eX1L7

07.01.2026 17:37 β€” πŸ‘ 2    πŸ” 0    πŸ’¬ 1    πŸ“Œ 0
PNAS Proceedings of the National Academy of Sciences (PNAS), a peer reviewed journal of the National Academy of Sciences (NAS) - an authoritative source of high-impact, original research that broadly spans...

🚨 New from our lab in @PNASNews: We developed a physiologically based model to optimize CAR-T therapy in solid tumors. Vascular normalization can cut CAR-T doses 5x & boost efficacy in tough tumors like glioblastoma & PDAC. www.pnas.org/doi/10.1073/... @mgbresearch.bsky.social

12.11.2025 17:05 β€” πŸ‘ 1    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
PNAS Proceedings of the National Academy of Sciences (PNAS), a peer reviewed journal of the National Academy of Sciences (NAS) - an authoritative source of high-impact, original research that broadly spans...

This work was recently published in PNAS by our team and collaborators. Read the full paper here www.pnas.org/doi/10.1073/...

17.09.2025 16:40 β€” πŸ‘ 1    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Research Spotlight: Combination Therapy Shows Promise for Overcoming Treatment Resistance in Glioblastoma | Mass General Brigham Glioblastoma (GBM) is a deadly brain cancer. Current treatments, including a type of immunotherapy called anti-PD1, don’t work well for most patients. New research has identified a promising new treat...

Excited to share our recent discovery on combination therapy strategies to overcome treatment resistance in glioblastoma, now highlighted by
@MassGeneralNew @harvardmed.bsky.social www.massgeneralbrigham.org/en/about/new...

17.09.2025 16:40 β€” πŸ‘ 1    πŸ” 1    πŸ’¬ 1    πŸ“Œ 0
Post image

Publication alert 🚨 Mutant p53 hijacks enhancers to drive CXCL1 expression and create an immunosuppressive TME in #PDAC. Targeting these enhancer-chemokine circuits could boost immunotherapy in PDAC. t.co/K84OB4NlOx #MGHCancerCenter #kochinstitute @harvardmed.bsky.social

30.06.2025 18:54 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

Honored to see our Director, Dr. Rakesh Jain, recognized for his pioneering work in intravital microscopy and the tumor microenvironment. A true visionary in cancer research!
#AACR25 #TME #IntravitalMicroscopy

17.06.2025 20:10 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Preview
A window to cancer’s soul: the creation of intravital microscopy and the rise of the TME We discuss the tumor microenvironment and intravital microscopy with its inventor Rakesh Jain, a pioneer of the TME.

We caught up with the @theaacr.bsky.social Award for Lifetime Achievement in Cancer Research winner, Rakesh Jain (@harvardmed.bsky.social) to discuss his pioneering work in the tumor microenvironment and invention of the intravital microscopy imaging method.
www.biotechniques.com/cancer-resea...

17.06.2025 17:54 β€” πŸ‘ 0    πŸ” 1    πŸ’¬ 0    πŸ“Œ 1
Mathematical Modeling and Association Analysis Deciphers the Impact of the Gut Microbiome on Cancer Immunotherapy Abstract. The gut microbiome has emerged as a key regulator of response to cancer immunotherapy. However, a better understanding of the underlying mechanisms by which the microbiome influences immunot...

New publication Alert! We developed a mathematical model to decipher how the gut microbiome shapes cancer immunotherapy response. Key insight: Microbiome composition influences immune cell activation & killing ratesβ€”critical for tumor control. @harvard.edu @mghsteelelabs.bsky.social

29.05.2025 14:56 β€” πŸ‘ 2    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Preview
Using mathematical modelling and AI to improve delivery and efficacy of therapies in cancer - Nature Reviews Cancer Here Harkos et al. review the role of continuous models and discrete models in predicting and understanding therapy delivery and efficacy in solid tumours. They propose ways to integrate mechanistic a...

We review how mathematical modeling and AI can be combined to improve delivery & efficacy of molecular, nano, antibody & cellular therapies in solid tumors. www.nature.com/articles/s41... #TME #AIinOncology #CancerResearch @harvard.edu

27.05.2025 14:25 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

Dr. Rakesh Jain of @mghsteelelabs.bsky.social shared insights from his decades-long work on vascular normalizationβ€”from concept to clinic. His lecture emphasized strategies to improve tumor vessel function and how these principles are transforming cancer therapy today.
#AACR2025 @harvard.edu

19.05.2025 16:19 β€” πŸ‘ 2    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

@mghsteelelabs is following 9 prominent accounts